IMMUSE™ – The Key to Health and Resilience
Kyowa Hakko’s parent company, Kirin Holdings, recently received the prestigious 1st STOP Infectious Disease Award at the 2021 Japanese Resilience Awards. This honor was bestowed upon Kirin for its groundbreaking discovery of the Lactococcus lactis strain Plasma (LC-Plasma) and its achievement in obtaining “foods with functional claim” registration from the Japanese Consumer Affairs Agency. The award not only recognizes Kirin’s innovative efforts but also highlights its significant contribution to national health policies aimed at improving the well-being of the Japanese population.
Helping Japanese Stay Healthy
As part of the Kirin Group Vision 2027, a comprehensive long-term management plan focused on creating value in various sectors, including food and medicine, the company has initiated a Health Science program. This initiative aims to assist individuals in maintaining their health and fitness by introducing immune health products containing LC-Plasma with labels indicating “foods with functional claims for immune-system support.” In 2021, Kirin expanded its product range to include 22 items containing LC-Plasma, such as functional beverages, yogurts, and chewables, making immune system maintenance more accessible to the average Japanese consumer.
About the Association for Resilience Japan
Established in 2014, the Association for Resilience Japan is dedicated to promoting and implementing the Japanese government’s Fundamental Plan for National Resilience. This plan, based on the Basic Act for National Resilience, focuses on preventing and mitigating disasters to enhance resilience in the lives of citizens. The association’s goal is to foster national resilience through collaborative efforts involving industry, academia, government, and the private sector. By raising awareness and encouraging action, the association aims to create a resilient nation capable of overcoming significant challenges.
The 1st STOP Infectious Disease Award
The STOP Infectious Disease Award, introduced in 2021 as part of the Japanese Resilience Awards, recognizes advanced initiatives that contribute to infectious disease control. Kirin Holding’s LC-Plasma, also known as IMMUSE™ in certain markets, is a proprietary strain of lactic acid bacteria scientifically proven to enhance immune function at the cellular level. This breakthrough in immune health supplements is distributed globally by Kyowa Hakko Bio Co., LTD. The Japanese Resilience Awards, now in their eighth year, honor organizations that play a vital role in strengthening the nation, regions, people, and industries.
In conclusion, IMMUSE™ and Kirin Holdings’ innovative approach to health and resilience have garnered significant recognition and praise. By prioritizing immune system support and public health initiatives, Kirin is not only contributing to the well-being of the Japanese population but also setting a benchmark for other companies to follow. As we navigate through challenging times, the importance of health and resilience cannot be overstated, and IMMUSE™ stands out as a leading solution in this critical area.
Learn More About IMMUSE™ (LC-Plasma)